Comparing Antimicrobial Susceptibilities among Mycoplasma pneumoniae Isolates from Pediatric Patients in Japan between Two Recent Epidemic Periods

Antimicrob Agents Chemother. 2019 Jun 24;63(7):e02517-18. doi: 10.1128/AAC.02517-18. Print 2019 Jul.

Abstract

We compared the antimicrobial susceptibility of Mycoplasma pneumoniae isolates from pediatric patients in Japan in 2011-2012 and 2015-2016, when epidemics occurred. The antimicrobial activity of macrolides and tetracyclines against M. pneumoniae infection tended to be restored in 2015-2016. There was no change in the antimicrobial activity of quinolones against M. pneumoniae infection.

Keywords: Japan; Mycoplasma pneumoniae; antimicrobial susceptibility; children; epidemic.

Publication types

  • Comparative Study

MeSH terms

  • Anti-Infective Agents / therapeutic use*
  • Child
  • Epidemics
  • Humans
  • Japan / epidemiology
  • Macrolides / therapeutic use
  • Microbial Sensitivity Tests / methods
  • Mycoplasma pneumoniae / drug effects*
  • Mycoplasma pneumoniae / isolation & purification
  • Pneumonia, Mycoplasma / drug therapy*
  • Pneumonia, Mycoplasma / epidemiology
  • Pneumonia, Mycoplasma / microbiology
  • Tetracyclines / therapeutic use

Substances

  • Anti-Infective Agents
  • Macrolides
  • Tetracyclines